In modern pharmaceutical and nutraceutical development, omega-3 fatty acids remain central to cardiometabolic and anti-inflammatory health. Fish oil has traditionally dominated because of its direct EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) content.